Search Result "EML4-ALK"
EGFR and EML4-ALK Updated Therapies in Non-Small Cell Lung Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 11 Issue: 4 Year: 2016 Page: 393-400
Author(s): Ramon Andrade De Mello,Davi J. J. Liu,Pedro N. Aguiar,Hakaru Tadokoro
CT-707 Overcomes Resistance of Crizotinib through Activating PDPK1- AKT1 Pathway by Targeting FAK
Journal: Current Cancer Drug Targets
Volume: 19 Issue: 8 Year: 2019 Page: 655-665
Author(s): Caixia Liang,Ningning Zhang,Qiaoyun Tan,Shuxia Liu,Rongrong Luo,Yanrong Wang,Yuankai Shi,Xiaohong Han
Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 3 Year: 2010 Page: 236-249
Author(s): Mangeng Cheng, Gregory R. Ott
Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 6 Year: 2017 Page: 590-613
Author(s): Jingru Liu,Shutao Ma
MicroRNAs and Targeted Therapies in Non-small Cell Lung Cancer: Minireview
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 6 Year: 2015 Page: 694-700
Author(s): Carmelo Tibaldi,Armida DâIncecco,Alessandro Lagana
A Pan-Cancer Review of ALK Mutations: Implications for Carcinogenesis and Therapy
Journal: Current Cancer Drug Targets
Volume: 15 Issue: 4 Year: 2015 Page: 327-336
Author(s): Nick Ka Ming Yau,Andrew Yuon Fong,Hiu Fung Leung,Krista Roberta Verhoeft,Qin Ying Lim,Wai Yip Lam,Ian Chi Kei Wong,Vivian Wai Yan Lui
Anaplastic Lymphoma Kinase Inhibitors in Non-Small Cell Lung Cancer
Journal: Current Drug Targets
Volume: 17 Issue: 6 Year: 2016 Page: 739-745
Author(s): David M. Straughan, Sa d C. Azoury, Vivek Shukla
Targeted Therapies and other Agents as First-Line Maintenance and Beyond: Particular Benefit in Pulmonary Adenocarcinoma Patients
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 1640-1650
Author(s): F. Petrelli, K. Borgonovo, M. Cabiddu, M. Ghilardi, S. Barni
Hsp90 Inhibitors as Anti-Cancer Agents, from Basic Discoveries to Clinical Development
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 366-376
Author(s): Shiro Soga,Shiro Akinaga,Yukimasa Shiotsu
3D-QSAR, Molecular Docking and Molecular Dynamics Studies of 2,4- Diarylaminopyrimidine Analogues (DAAP Analogues) as Potent ALK Inhibitors
Journal: Letters in Drug Design & Discovery
Volume: 14 Issue: 3 Year: 2017 Page: 270-286
Author(s): Fulong Wu,Qianqian Lv,Zhonghua Wang,Dandan Li,Peng Peng,Yan Yin,Siheng Cui,Fanhong Wu